Janus Henderson Group PLC Eli Lilly & CO Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,141,246 shares of LLY stock, worth $3.39 Billion. This represents 2.06% of its overall portfolio holdings.

Number of Shares

4,141,246

Previous 3,575,684 15.82%

Holding current value

$3.39 Billion

Previous $2.78 Billion 34.79%

% of portfolio

2.06%

Previous 1.56%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $410 Million - $514 Million	565,562 Added 15.82%	4,141,246 $3.75 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $144 Million - $193 Million	243,729 Added 7.31%	3,575,684 $2.78 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $481 Million - $567 Million	915,324 Added 37.88%	3,331,955 $1.94 Billion
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $39.3 Million - $54.2 Million	-90,379 Reduced 3.61%	2,416,631 $1.3 Billion
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $293 Million - $391 Million	-834,119 Reduced 24.97%	2,507,010 $1.18 Billion
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $93 Million - $109 Million	-299,541 Reduced 8.23%	3,341,129 $1.15 Billion
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $25.7 Million - $29.9 Million	-79,912 Reduced 2.15%	3,640,670 $1.33 Billion
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $62.9 Million - $71.7 Million	-212,073 Reduced 5.39%	3,720,582 $1.2 Billion
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $320 Million - $376 Million	-1,147,952 Reduced 22.59%	3,932,655 $1.28 Billion
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $89.1 Million - $111 Million	-379,771 Reduced 6.96%	5,080,607 $1.45 Billion
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $153 Million - $190 Million	680,641 Added 14.24%	5,460,378 $1.51 Billion
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $20.4 Million - $25.1 Million	-92,003 Reduced 1.89%	4,779,737 $1.1 Billion
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $25.3 Million - $32.7 Million	-140,005 Reduced 2.79%	4,871,740 $1.12 Billion
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $183 Million - $237 Million	-1,113,176 Reduced 18.17%	5,011,745 $936 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $39.4 Million - $52.2 Million	302,296 Added 5.19%	6,124,921 $1.03 Billion
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $37.8 Million - $43.7 Million	258,330 Added 4.64%	5,822,625 $862 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $107 Million - $129 Million	786,253 Added 16.46%	5,564,295 $914 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $57.9 Million - $71.6 Million	-486,130 Reduced 9.23%	4,778,042 $663 Million
Q4 2019 Feb 18, 2020	SELL	$106.92 - $132.43 $99.7 Million - $123 Million	-932,458 Reduced 15.05%	5,264,172 $692 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $43.9 Million - $47.7 Million	-410,806 Reduced 6.22%	6,196,630 $693 Million
Q2 2019 Jul 31, 2019	SELL	$110.79 - $129.32 $246 Million - $287 Million	-2,217,899 Reduced 25.13%	6,607,436 $732 Million
Q1 2019 Apr 30, 2019	SELL	$111.31 - $131.02 $13.9 Million - $16.3 Million	-124,561 Reduced 1.39%	8,825,335 $1.15 Billion
Q4 2018 Feb 06, 2019	SELL	$105.9 - $118.64 $22.6 Million - $25.3 Million	-213,599 Reduced 2.33%	8,949,896 $1.04 Billion
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $72.6 Million - $90.7 Million	-845,273 Reduced 8.45%	9,163,495 $983 Million
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $53 Million - $60.9 Million	700,582 Added 7.53%	10,008,768 $854 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $52.6 Million - $62.1 Million	-708,562 Reduced 7.07%	9,308,186 $720 Million
Q4 2017 Feb 09, 2018	SELL	$81.94 - $87.89 $68.9 Million - $73.9 Million	-840,445 Reduced 7.74%	10,016,748 $846 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $116 Million - $129 Million	1,503,918 Added 16.08%	10,857,193 $0
Q2 2017 Aug 17, 2017	BUY	N/A	9,353,275	9,353,275 $770 Million

Others Institutions Holding LLY

# of Institutions

3,950

Shares Held

763M

Call Options Held

6.32M

Put Options Held

8.59M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $778B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Eli Lilly & CO Transaction History